Evan Kovac, MD, CM, FRCSC

Evan Kovac, MD, CM, FRCSC, is an Associate Professor and Director of Urologic Oncology at Rutgers University in Newark, New Jersey. Dr. Kovac also serves as the Associate Program Director of the Urology Residency at Rutgers University. He specializes in the evaluation and treatment of cancers of the urinary tract, including prostate, kidney, bladder, testicular, adrenal and penile cancers. Dr. Kovac has specific expertise in ultrasound-MRI fusion biopsy for the diagnosis of prostate cancer, as well as, endoscopic and robotic surgery techniques for the treatment of genitourinary cancers.

Dr. Kovac earned his medical degree and completed a residency in Urology at McGill University in Montreal, Canada. He then completed a fellowship in Urologic Oncology and Robotics at the Cleveland Clinic in Cleveland, Ohio. Dr. Kovac is a Fellow of the Royal College of Surgeons of Canada.

Dr. Kovac has authored and co-authored over 60 publications and book chapters on urologic oncology. He is considered a leader in the optimization of prostate-specific antigen screening for the early detection of prostate cancer. Dr. Kovac led a collaboration with primary care physicians to create a novel prostate cancer screening decision aid designed specifically for multi-ethnic, underserved communities. He also led the establishment of a first-of-its-kind prostate cancer center in the Bronx, New York.